Certain statements in this section and other parts of this Quarterly Report on Form 10-Q may constitute "forward-looking statements" within the meaning of the federal securities laws and are entitled to the safe-harbor provisions of the PSLRA.Outstanding borrowings under the Credit Agreement bear interest, at the Company’s option, at either LIBOR, fixed for interest periods of one, two, three or six-month periods, plus 1.00% to 2.00%, or at the bank’s Base Rate, as defined, plus 0.00% to 1.00%, based upon the Company’s Consolidated Leverage Ratio, as defined.
Senior Notes, Series A due 2022”), and $100 million in aggregate principal amount of 3.74% Senior Notes, Series B, due February 15, 2027 (“U.S.
Net cash provided by operating activities was $160.9 million for the nine months ended September 28, 2019, compared to $252.1 million during the nine months ended September 29, 2018.
Gross profit was $130.9 million, or 36.2% of net sales, in the third quarter of 2019 compared to $179.6 million, or 40.9% of net sales, in the third quarter of 2018.
On December 8, 2016, the Company entered into a Note Purchase Agreement, pursuant to which the Company issued and sold €212 million aggregate principal amount of senior notes in two series.
The Company recognized net income of $35.6 million, or $1.44 per diluted share, in the third quarter of 2019 compared to net income of $53.5 million, or $2.10 per diluted share in the third quarter of 2018.
The third quarter of 2019 includes $5.7 million ($17.9 million year-to-date) of non-segment charges, of which $2.5 million ($11.0 million year-to-date) of restructuring charges are primarily related to employee termination costs and other restructuring charges and $3.2 million ($6.9 million year-to-date) of acquisition-related and integration charges are primarily related to the IXYS acquisition and other contemplated acquisitions.
Term Loans may be made in up to two advances.
Income before income taxes was $141.4 million, or 12.1% of net sales, for the first nine months of 2019 compared to $165.2 million, or 12.5% of net sales, for the first nine months of 2018.
Cautionary Statement Regarding Forward-Looking Statements Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”).
The third quarter of 2019 includes $5.7 million ($17.9 million year-to-date) of non-segment charges, of which $2.5 million ($11.0 million year-to-date) of restructuring charges are primarily related to employee termination costs and other restructuring charges and $3.2 million ($6.9 million year-to-date) of acquisition-related and integration charges are primarily related to the IXYS acquisition and other contemplated acquisitions.
The effective tax rate for the 2019 period is lower than the effective tax rate for the 2018 period primarily due to lower taxes in certain non-US jurisdictions , including the impact of a tax holiday in China which was applicable in the 2019 period but not the 2018 period.
Operating income was $47.2 million, a decrease of $29.1 million, or 38.1%, for the third quarter of 2019 compared to $76.2 million for the third quarter of 2018.
The Company has historically supported its liquidity needs through cash flows from operations.
The Company recognized net income of $35.6 million, or $1.44 per diluted share, in the third quarter of 2019 compared to net income of $53.5 million, or $2.10 per diluted share in the third quarter of 2018.
Additionally, dividends paid increased $3.7 million from $29.3 million in 2018 to $33.0 million for the nine months ended September 28, 2019.
The Company’s Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP.There are 500,000 shares yet to be purchased under the 2019 program as of September 28, 2019.